Pharmedic Pharmaceutical Medicinal Past Earnings Performance
Past criteria checks 5/6
Pharmedic Pharmaceutical Medicinal has been growing earnings at an average annual rate of 2.7%, while the Pharmaceuticals industry saw earnings growing at 12.1% annually. Revenues have been growing at an average rate of 0.5% per year. Pharmedic Pharmaceutical Medicinal's return on equity is 24.5%, and it has net margins of 12.5%.
Key information
2.7%
Earnings growth rate
2.8%
EPS growth rate
Pharmaceuticals Industry Growth | 13.0% |
Revenue growth rate | 0.5% |
Return on equity | 24.5% |
Net Margin | 12.5% |
Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Pharmedic Pharmaceutical Medicinal makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Mar 24 | 483,237 | 60,543 | 85,742 | 0 |
31 Dec 23 | 485,186 | 61,002 | 85,645 | 0 |
30 Sep 23 | 479,793 | 59,343 | 85,205 | 0 |
30 Jun 23 | 455,205 | 58,958 | 87,292 | 0 |
31 Mar 23 | 458,681 | 57,574 | 91,178 | 0 |
31 Dec 22 | 472,274 | 60,894 | 95,588 | 0 |
30 Sep 22 | 484,469 | 67,381 | 96,812 | 0 |
30 Jun 22 | 408,974 | 50,044 | 79,213 | 0 |
31 Mar 22 | 414,456 | 48,426 | 77,439 | 0 |
31 Dec 21 | 414,232 | 47,275 | 74,912 | 0 |
30 Sep 21 | 404,788 | 39,497 | 73,717 | 0 |
30 Jun 21 | 470,852 | 54,872 | 89,343 | 0 |
31 Mar 21 | 448,821 | 51,182 | 87,837 | 0 |
01 Jan 21 | 460,764 | 54,471 | 90,801 | 0 |
30 Sep 20 | 457,843 | 55,101 | 92,709 | 0 |
30 Jun 20 | 462,437 | 55,899 | 93,602 | 0 |
31 Mar 20 | 480,477 | 57,591 | 95,282 | 0 |
01 Jan 20 | 464,772 | 54,327 | 92,315 | 0 |
30 Sep 19 | 457,778 | 53,695 | 91,678 | 0 |
30 Jun 19 | 453,927 | 52,533 | 90,213 | 0 |
31 Mar 19 | 451,776 | 52,123 | 90,064 | 0 |
31 Dec 18 | 454,572 | 53,764 | 92,488 | 0 |
30 Sep 18 | 444,018 | 53,133 | 91,375 | 0 |
30 Jun 18 | 443,797 | 54,628 | 93,880 | 0 |
31 Mar 18 | 432,685 | 54,035 | 93,138 | 0 |
31 Dec 17 | 429,602 | 53,101 | 94,243 | 0 |
30 Sep 17 | 430,901 | 53,618 | 96,619 | 0 |
30 Jun 17 | 424,091 | 53,513 | 96,023 | 0 |
31 Mar 17 | 425,209 | 54,468 | 97,098 | 0 |
31 Dec 16 | 413,937 | 53,971 | 94,152 | 0 |
30 Sep 16 | 409,114 | 54,851 | 91,620 | 0 |
30 Jun 16 | 403,985 | 52,512 | 90,829 | 0 |
31 Mar 16 | 398,975 | 49,505 | 88,215 | 0 |
31 Dec 15 | 387,659 | 46,664 | 86,558 | 0 |
30 Sep 15 | 380,494 | 46,445 | 86,455 | 0 |
30 Jun 15 | 371,140 | 45,053 | 84,258 | 0 |
31 Mar 15 | 367,585 | 45,426 | 85,449 | 0 |
31 Dec 14 | 363,476 | 45,500 | 85,090 | 0 |
30 Sep 14 | 365,586 | 61,958 | 84,054 | 0 |
30 Jun 14 | 366,444 | 60,818 | 82,988 | 0 |
31 Mar 14 | 363,936 | 58,832 | 80,852 | 0 |
31 Dec 13 | 357,362 | 55,633 | 77,484 | 0 |
30 Sep 13 | 344,510 | 51,926 | 72,295 | 0 |
30 Jun 13 | 327,819 | 48,360 | 66,880 | 0 |
Quality Earnings: PMC has high quality earnings.
Growing Profit Margin: PMC's current net profit margins (12.5%) are lower than last year (12.6%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: PMC's earnings have grown by 2.7% per year over the past 5 years.
Accelerating Growth: PMC's earnings growth over the past year (5.2%) exceeds its 5-year average (2.7% per year).
Earnings vs Industry: PMC earnings growth over the past year (5.2%) exceeded the Pharmaceuticals industry -6.6%.
Return on Equity
High ROE: PMC's Return on Equity (24.5%) is considered high.